论文部分内容阅读
目的:观察贝那普利辅助治疗早期糖尿病肾病(DN)的临床疗效。方法:将120例DN患者随机分为观察组和对照组各60例,对照组给予常规治疗,观察组在常规治疗基础上加用贝那普利治疗。结果:观察组疗效优于对照组(P<0.01),且治疗后MA/Cr、Scr及24 h尿蛋白水平均较对照组改善明显(P<0.01)。结论:贝那普利辅助治疗早期DN效果理想,可明显改善临床症状及肾功能水平,值得临床推广。
Objective: To observe the clinical efficacy of benazepril in the treatment of early diabetic nephropathy (DN). Methods: A total of 120 patients with DN were randomly divided into observation group and control group, 60 cases in each group. The control group was given routine treatment. The observation group was treated with benazepril on the basis of conventional treatment. Results: The curative effect of the observation group was better than that of the control group (P <0.01), and the levels of MA / Cr, Scr and 24 h urine protein after treatment were significantly improved compared with the control group (P <0.01). Conclusion: Benazepril adjuvant treatment of early DN results are satisfactory, can significantly improve the clinical symptoms and renal function, worthy of clinical promotion.